Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities.

Human insulin receptor isoforms (HIR-A and -B) differ in their alpha-subunit structures which result from alternatively spliced precursor mRNAs. This structural difference causes distinct binding affinities for insulin. To determine the impact of the structural difference on receptor signaling, we characterized the tyrosine kinase activity of HIR-A and HIR-B in vitro and determined the insulin stimulated beta-subunit phosphorylation and tyrosine kinase activation in the intact cell. When 32P incorporation in beta-subunits of equal amounts of isolated HIR-A and HIR-B was measured, an increased 32P incorporation in tyrosine residues of the beta-subunit of HIR-B (2.5-fold) compared to that of HIR-A was found after in vitro insulin stimulation. This was paralleled by an increased rate of phosphorylation (2.0-fold) or poly(GluNa,Tyr 4:1). In vitro analysis of Km values for ATP were similar for HIR-A (Km = 14.3 microM +/- 3.8) and HIR-B (Km = 20.2 microM +/- 8.6), whereas the Vmax of HIR-B was significantly increased (HIR-A Vmax = 5.5 mumol/60 min micrograms-1 +/- 1.4, HIR-B Vmax = 42.5 mumol/60 min micrograms-1 +/- 19.2). HPLC analysis of tryptic beta-subunit phosphopeptides revealed identical patterns, suggesting that the difference in kinase activities is not due to an alteration of the phosphorylation-activation cascade within the beta-subunit. However, when cleavage of the alpha-subunit by short-time trypsinization was used to activate the tyrosine kinase, the differences in 32P incorporation between HIR-A and HIR-B were abolished.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  E. Schleicher,et al.  Insulin activates GTP binding to a 40 kDa protein in fat cells. , 1991, The Biochemical journal.

[2]  A. Ullrich,et al.  Functionally distinct insulin receptors generated by tissue‐specific alternative splicing. , 1990, The EMBO journal.

[3]  A. Ullrich,et al.  Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. , 1990, Cancer research.

[4]  C. Gorman,et al.  The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. , 1989, Virology.

[5]  G. Bell,et al.  Alternative splicing of human insulin receptor messenger RNA. , 1989, Biochemical and biophysical research communications.

[6]  C. Kahn,et al.  Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. , 1988, The Journal of biological chemistry.

[7]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[8]  H. Klein,et al.  Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo. , 1986, The Journal of biological chemistry.

[9]  K. Siddle,et al.  Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. , 1986, The Biochemical journal.

[10]  B. Obermaier,et al.  Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. , 1986, The Journal of biological chemistry.

[11]  D. Morgan,et al.  Purification and characterization of the human brain insulin receptor. , 1986, The Journal of biological chemistry.

[12]  B. Obermaier,et al.  Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. , 1986, The Biochemical journal.

[13]  C. Kahn,et al.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.

[14]  G A McPherson,et al.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. , 1985, Journal of pharmacological methods.

[15]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[16]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[17]  C. Kahn,et al.  Phosphorylation and dephosphorylation of the insulin receptor: evidence against an intrinsic phosphatase activity. , 1984, Biochemistry.

[18]  E. Racker,et al.  Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. , 1984, The Journal of biological chemistry.

[19]  C. Kahn,et al.  Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. , 1984, The Journal of biological chemistry.

[20]  C. Kahn,et al.  Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. , 1982, The Journal of biological chemistry.

[21]  E. Van Obberghen,et al.  Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. , 1981, The Journal of biological chemistry.

[22]  J. Turtle,et al.  Purification of the insulin receptor from human placental membranes. , 1979, Biochimica et biophysica acta.

[23]  M. Czech,et al.  Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons. , 1979, The Journal of biological chemistry.

[24]  C. Kahn,et al.  A Cascade of Tyrosine Autophosphorylation in the &Subunit Activates the Phosphotransferase of the Insulin Receptor* , 2001 .

[25]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[26]  M. F. White,et al.  Insulin rapidly stimulates phosphorylation of a 46-kDa membrane protein on tyrosine residues as well as phosphorylation of several soluble proteins in intact fat cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. V. Van Wyk,et al.  Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. , 1980, The Journal of clinical endocrinology and metabolism.